Biotech

All Articles

A nearer check out Intense Biotech's Fierce 15

.Within this week's incident of "The Top Pipe," our team're diving right into Fierce Biotech's yearl...

Lilly deals with phase 2 breakdown of tau-targeting med

.The confetti is still soaring from Eli Lilly's celebration celebrating the approval of Alzheimer's ...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our summary of significant leadership hirings, shootings as ...

Lykos are going to inquire FDA to reexamine its decision following rejection of MDMA therapy for trauma

.Observing a poor revealing for Lykos Rehabs' MDMA applicant for post-traumatic stress disorder at a...

AN 2 fifty percents headcount, ceases phase 3 trial after records let down

.AN2 Therapeutics is reconsidering its own service in reaction to poor midphase information, pledgin...

Merck pays out $700M for bispecific, spying autoimmune position and also odds to challenge Amgen in cancer

.Merck &amp Co. is paying for $700 thousand ahead of time to test Amgen in a blood stream cancer mar...

Gilead pays for J&ampJ $320M to go out licensing package for seladelpar

.With Gilead Sciences on the verge of an FDA choice for its liver illness drug seladelpar, the provi...

' All hands on deck' at Lilly as peers target excessive weight market

.Chief executive officer David Ricks may see the companies setting up outdoors tents at basecamp beh...

Entero laying off workers, moving out of workplace and also stopping briefly R&ampD

.Bed mattress Liquidators has actually switched Entero Rehabs white colored as a sheet. The financia...

Exelixis drops ADC after choosing it's no suit for Tivdak

.Exelixis is surrendering on its own cells variable (TF)- targeting antibody-drug conjugate after co...